Skip to content

Explorative investigation towards the effectivity of a special lighting solution in influencing 25(OH)D serum levels

Explorative investigation towards the effectivity of a special lighting solution in influencing 25(OH)D serum levels - Vitamin D3 pilot

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49492
Enrollment
28
Registered
2020-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VIT D insufficiency and general wellbeing by bringing the benefits of natural daylight inside (i.e. ultra small dose UV-B for VIT D) VIT D insufficiency

Interventions

The individual workspaces of 14 office workers will be equipped with the desk-based intervention light and subsequently be exposed to a low dose of artificial UVB during daytime hours with a maximum

Sponsors

Signify research (previously Philips Research)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Age over 18 years old * Fitzpatrick skin type II or III * Desk presence of at least 2,5 days per week during the 8 weeks study period or at least 4 days present in the office. * Medically fit to work the hours as contractually agreed

Exclusion criteria

Exclusion criteria: * * Current pregnancy, breast feeding or a desire to become pregnant * Office workers with malignant skin conditions in the past or currently * Photosensitive medical conditions or photo-sensitising drugs * Users of medicines and/or cremes mentioning in the prescription as side effect extra sensitivity to the sun * Planned use of sun beds, or sunbed use during the past 4 weeks * Currently taking or planning to take oral vitamin D3 supplements or have been taking D3 supplements during the past 4 weeks. * High vitamin D levels at the start of the study (>375 nmol/L) which need medical attention

Design outcomes

Primary

MeasureTime frame
The main study parameter is the difference in 25(OH)D serum levels.

Secondary

MeasureTime frame
self reported indicators of sleep timing, sleep quality and general levels of fatigue.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)